Skip to content

Addiction: all studies

Page 435 of 857: studies 4,341 to 4,350 of 8,563, newest first. Back to the addiction overview

Research

Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder.

Frontiers in Psychiatry 2023 Angela N Phan, Garth E Terry 6 citations

Cannabis use disorder (CUD) is prevalent in ~2-5% of adults in the United States and is anticipated to increase as restrictions to cannabis decrease and tetrahydrocannabinol (THC) content in cannabis products increase. No FDA-approved medications for CUD are currently available, despite trials of dozens of re-purposed and novel drugs. Psychedelics have garnered interest as a therapeutic class...

Adapting psychedelic medicine for headache and chronic pain disorders.

Expert Review of Neurotherapeutics 2023 Emmanuelle A. D. Schindler, Peter S. Hendricks 5 citations

While the majority of current research and development surrounds depression, demoralization, and substance use disorders, there are numerous reports of psychedelics having beneficial effects in other branches of medicine, including for headache disorders and chronic pain. This perspective reviews conventional forms of treatment for headache and other chronic pain disorders and describes...

Ayahuasca, Personality and Acute Psychological Effects in Neo-Shamanic and Religious Settings in Uruguay.

Journal of Psychoactive Drugs 2023 Ismael Apud, Juan Scuro, Luisina Rodríguez et al. 4 citations

This study is an interdisciplinary research into Uruguayan ayahuasca users belonging to one neo-shamanic and one Santo Daime group. The study involved the chemical analysis of ayahuasca samples, an ethnographic description of the two traditions and rituals, and the application of psychometric scales to measure personality differences, and the acute psychological effects during an ayahuasca...

DOI: 10.1080/02791072.2023.2261017 (opens in new tab) Full text (opens in new tab) Santo daime Acute psychological effects Neo-shamanism Personality +6

A pilot study of cerebral metabolism and serotonin 5-HT2A receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine.

Frontiers in Pharmacology 2023 Klemens Egger, Frederik Gudmundsen, Naja Støckel Jessen et al. 17 citations

Rationale: The psychedelic effects of the traditional Amazonian botanical decoction known as ayahuasca are often attributed to agonism at brain serotonin 5-HT2A receptors by N,N-dimethyltryptamine (DMT). To reduce first pass metabolism of oral DMT, ayahuasca preparations additionally contain reversible monoamine oxidase A (MAO-A) inhibitors, namely β-carboline alkaloids such as harmine....

Anomalous Cognition: An Umbrella Review of the Meta-Analytic Evidence

Journal of Anomalous Experience and Cognition December 30, 2022 Patrizio Tressoldi, Lance Storm 12 citations

Objective: The aim of this study was to assess the results of all meta-analyses on anomalous cognition conducted between 1989 and 2021 in order to find moderators associated with greater effect sizes. Method: We included all meta-analyses of studies related to anomalous cognition published up to 2021. Results: Our dataset, accumulated over more than 80 years of investigation, refers to 11...

DOI: 10.31156/jaex.23206 (opens in new tab) Full text (opens in new tab) Anomalous cognition Free response Forced choice ´physiological responses +4

Single-lead ECG based autonomic nervous system assessment for meditation monitoring.

Scientific Reports December 29, 2022 Chanki Park, Inchan Youn, Sungmin Han

We propose a single-lead ECG-based heart rate variability (HRV) analysis algorithm to quantify autonomic nervous system activity during meditation. Respiratory sinus arrhythmia (RSA) induced by breathing is a dominant component of HRV, but its frequency depends on an individual's breathing speed. To address this RSA issue, we designed a novel HRV tachogram decomposition algorithm and new HRV...

Effects of acute Δ9 -tetrahydrocannabinol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice

Research Square December 29, 2022 Barkha J. Yadav-Samudrala, Ben L. Gorman, Hailey Dodson et al. 1 citation preprint

Abstract Cannabis use is highly prevalent especially among people living with HIV (PLWH). Activation of the anti-inflammatory and neuroprotective endocannabinoid system by phytocannabinoids, i.e. Δ9-tetrahydrocannabinol (THC), has been proposed to reduce HIV symptoms. However, THC’s effects on HIV-associated cognitive impairments are unclear. Using HIV-1 Tat transgenic mice, the current study...

Ketamine modulates a norepinephrine-astroglial circuit to persistently suppress futility-induced passivity

bioRxiv Preprint Server December 29, 2022 Marc Duque, Alex B. Chen, Eric Hsu et al. 1 citation preprint

Mood-altering compounds hold promise for the treatment of many psychiatric disorders, such as depression, but connecting their molecular, circuit, and behavioral effects has been challenging. Here we find that, analogous to effects in rodent learned helplessness models, ketamine pre-exposure persistently suppresses futility-induced passivity in larval zebrafish. While antidepressants are...

DOI: 10.1101/2022.12.29.522099 (opens in new tab) Full text (opens in new tab) Ketamine dissociative anesthetic Mood-altering compound Astroglia astrocytes Star-shaped brain cells +11

How Effective Are Mindfulness-Based Interventions for Reducing Stress and Weight? A Systematic Review and Meta-Analysis

International Journal of Environmental Research and Public Health December 27, 2022 Elena Sosa‐Cordobés, Juan Diego Ramos‐Pichardo, José Luis Sánchez‐Ramos et al. 28 citations

Stress contributes to the development and maintenance of obesity. Mindfulness-based therapies are being used to reduce stress and promote weight reduction and maintenance. This study aimed to determine the efficacy of mindfulness-based interventions for stress and weight reduction in the short, medium, and long term. Searches on PsycINFO, Medline, CINAHL, Scopus, WOS, and Science Direct were...

Systematic use of LSD, mephedron and amanita muscaria without signs mental and addictive pathology. The case of Daria D.

Neurology Bulletin December 24, 2022 Vladimir D. Mendelevich, Veronika N. Konovalova, Galya M. Galiullina et al.

The article describes the case of Daria D., 23 years old, who has been using various drugs (LSD, marijuana, mephedrone) for a number of years and independently abandoned using drags with the transition to the use of microdoses of red fly agaric (Amanita Muskaria). Her mental and addictive status is analyzed. It is concluded that, despite the systematic use of drugs, there are no grounds for...